Alkem Laboratories informs about company updates

12 Dec 2016 Evaluate

Alkem Laboratories has informed that US FDA had conducted an inspection at the Company’s API (Active Pharmaceutical Ingredient) manufacturing facility located at Ankleshwar, India from 5th December to 9th December, 2016. In this regard, the Company has received the inspection report which contains three 483 observations. The Company shall put together a detailed response with adequate corrective and preventive measures to address the US FDA Observations and the same is proposed to be filed within the timeline stipulated by US FDA.

The above information is a part of company’s filings submitted to BSE.

Alkem Laboratories Share Price

5527.10 -7.90 (-0.14%)
29-Dec-2025 10:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.40
Dr. Reddys Lab 1266.45
Cipla 1505.95
Zydus Lifesciences 907.65
Lupin 2101.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×